|Bid||2.3270 x 800000|
|Ask||2.4100 x 800000|
|Day's Range||2.3050 - 2.3050|
|52 Week Range||1.8690 - 4.6200|
|Beta (5Y Monthly)||1.75|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 06, 2017|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for G51.F
Global biotechnology corporation, GenScript Asia Pacific's President, Mr. Johnson Wang bagged the Executive of the Year - Biotechnology title at the recently held SBR Management Excellence Awards 2022 for his dedication to building up GenScript Asia Pacific team since 2019. The prestigious awards honor individuals or teams that have made a huge contribution to the companies' success and Singapore's growth.
GenScript USA Inc., the world's leading life-science research tools and services provider, has been named a BioSpace 2023 Best Place to Work. The list, now in its second year, includes 60 U.S. operating employers that have been recognized as the most sought-after in the industry by the life-sciences community.
GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP™. The Thai FDA has approved VAILL COVITRAP™ as a Class 4 medical device, makin